Improvement of intraperitoneal chemotherapy for rat ovarian cancer using cisplatin-containing microspheres

Japanese Journal of Cancer Research

Volumn 87, Issue 4, 1996, Pages 412-417

  Kumagai, Seisuke ^a   Sugiyama, Toru ^a   Nishida, Takashi ^a   Ushijima, Kimio ^a   Yakushiji, Michiaki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CDDP PLGA; Drug delivery system; Intraperitoneal administration; Ovarian cancer; Rat

Indexed keywords

CISPLATIN; COPOLYMER; GLYCOLIC ACID; LACTIC ACID; MICROSPHERE; PLATINUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TOXICITY; FEMALE; INTERMETHOD COMPARISON; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OVARY CANCER; PERITONEUM TUMOR; PHARMACEUTICS; PRIORITY JOURNAL; RAT;

EID: 0029942557     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00238.x     Document Type: Article

References (23)

1. Gregoriades, G. Targeting of drug. Nature, 265, 407-411 (1977).
2. Mizushima, Y., Shoji, Y., Saotome, T., Yanagawa, A. and Nakagawa, T. Current problems and future perspectives in drug delivery systems (DDS) for cancer therapy. Jpn. J. Cancer Chemother., 15, 1077-1082 (1988) (in Japanese).
3. Taguchi, T. Targeting therapy for cancer and DDS. Jpn. J. Cancer Chemother., 21, 736-737 (1994) (in Japanese).
4. Kotz, K. W. and Schilder, R. J. High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer. Semin. Oncol., 22, 250-262 (1995).
5. Malmstorm, H., Carstensen, J. and Simonsen, E. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer. Gynecol. Oncol., 54, 27-34 (1994).
6. Markman, M. Intraperitoneal cisplatin and carboplatin in the management of ovarian cancer. Semin. Oncol., 21, 17-19 (1994).
7. Noda, T., Saitoh, S., Ando, Y., Nakanishi, A., Maruya, C., Yoh, S., Hino, K., Kiyozuka, Y. and Ichijou, M. Intraperitoneal (IP) high-dose cisplatinum (CDDP) chemotherapy in patients with advanced ovarian cancer. J. Jpn. Soc. Cancer Ther., 20, 797-807 (1985).
8. Ryuko, K., Iwanari, O., Moriyama, M., Moriyama, S., Nakayama, O., Miyako, J. and Kitao, M. Intraperitoneal chemotherapy through implantable injection port in patients with advanced ovarian (or tubal) carcinoma. Jpn. J. Cancer Chemother., 18, 2052-2057 (1991) (in Japanese).
9. Noda, T., Oku, M., Kiyozuka, Y., Ninomiya, Y., Hino, K., Okamura, Y., Maruyama, M. and Ichijou, M. Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis. Jpn. J. Cancer Chemother., 14, 1025-1032 (1987) (in Japanese).
10. Jones, R. B., Collins, J. M., Myers, C. E., Brooks, A. E., Hubbard, S. M., Balow, J. E., Brennan, M. F., Dedrick, R. L. and DeVita, V. T. High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer. Cancer Res., 41, 55-59 (1981).
11. Dedrick, R. L., Myers, C. E., Bungy, P. M. and DeVita, V. T., Jr. Pharmakokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat. Rep., 62, 1-11 (1978).
12. Myers, C. E. and Collins, J. M. Pharmacology of intraperitoneal chemotherapy. Cancer Invest., 1, 395-407 (1983).
13. Hirabayashi, K. Intraperitoneal chemotherapy. Jpn. J. Cancer Chemother., 16, 180-186 (1989) (in Japanese).
14. Pretorius, G. R., Petrilli, S. E., Kean, C., Ford, C. L., Hoeschele, D. J. and Lagasse, D. L. Comparison of the iv and ip routes of administration of cisplatin in dogs. Cancer Treat. Rep., 65, 1055-1062 (1981).
15. Rusznyak, I., Foldi, M. and Szabo, G. "Lymphatics and Lymph Circulation," pp. 475-510 (1967). Pergamon Press, London.
16. Ikada, Y., Kyo, M. and Hyon, S.-H. Preparation of biodegradable microspheres for sustained release of cisplatin. Proc. Int. Symp. Control Relat. Bioact. Mater., 20, 462-463 (1993).
17. Ike, O., Shimizu, Y., Wada, R., Hyon, S.-H. and Ikada, Y. Controlled cisplatin delivery system using poly(D, L-lactic acid). Biomaterials, 13, 230-234 (1992).
18. Sugiyama, T., Yokota, D., Ushijima, K., Imaishi, K., Hirakawa, N., Nakanami, M., Nishida, T. and Yakushiji, M. An experimental model for advanced ovarian cancer. Kurume Med., 37, 15-21 (1990).
19. Imaishi, K. Intraperitoneal transplantation of ascitic cancer cells from a 7,12-dimethylbenz(a)anthracene (DMBA)-induced ovarian cancer. Kurume Med., 39, 195-201 (1992).
20. Ike, O., Wada, R., Kusanoi, Y., Watanabe, S., Hyon, S.-H., Ikada, Y. and Shimizu, Y. Cis-diamminedichloroplatinum delivery system using poly(lactic acid). Drug Delivery Syst., 5, 29-32 (1990).
21. Hagiwara, A., Takahashi, T., Kojima, O., Tamaguchi, T., Sasabe, T., Lee, M., Sakakura, C., Shoubayashi, S., Ikada, Y. and Hyon, S.-H. Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents. Cancer, 71, 844-850 (1993).
22. Hagiwara, A., Takahashi, T., Sasabe, T., Ito, M., Lee, M., Sakakura, C., Shoubayashi, S., Muranishi, S. and Tashima, S. Toxicity of a new dosage format, cisplatin incorporated in lactic acid oligomer microspheres, in mice. Anti-Cancer Drugs, 3, 237-244 (1992).
23. Hagiwara, A., Takahashi, T., Sasabe, T., Itou, M., Yoneyama, C., Shimotsuma, M., Iwamoto, A., Wada, R., Hyon, S.-H., Ikada, Y., Kusanoi, Y. and Muranishi, S. Superior therapeutic effects of cisplatin incorporated in lactic acid oligomer microspheres on peritoneal carcinomatosis in mice. J. Clin. Exp. Med., 152, 613-614 (1990) (in Japanese).